Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy

Singal, 1998, Doxorubicin-induced cardiomyopathy, N. Engl. J. Med., 339, 900, 10.1056/NEJM199809243391307 Slamon, 2001, Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2, N. Engl. J. Med., 344, 783, 10.1056/NEJM200103153441101 Allen, 2004, Drug delivery systems: entering the mainstream, Science, 303, 1818, 10.1126/science.1095833 Northfelt, 1998, Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial, J. Clin. Oncol., 16, 2445, 10.1200/JCO.1998.16.7.2445 Judson, 2001, Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL (R)/CAELYX (R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group, Eur. J. Cancer, 37, 870, 10.1016/S0959-8049(01)00050-8 O'Brien, 2004, Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX (TM)/Doxil (R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer, Ann. Oncol., 15, 440, 10.1093/annonc/mdh097 Gabizon, 2003, Pharmacokinetics of pegylated liposomal doxorubicin — review of animal and human studies, Clin. Pharmacokinet., 42, 419, 10.2165/00003088-200342050-00002 Seynhaeve, 2007, Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response, Cancer Res., 67, 9455, 10.1158/0008-5472.CAN-07-1599 Yatvin MB, 1978, Design of liposomes for enhanced local release of drugs by hyperthermia, Science, 202, 1290, 10.1126/science.364652 Needham, 2000, A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model, Cancer Res., 60, 1197 Lindner, 2004, Novel temperature-sensitive liposomes with prolonged circulation time, Clin. Cancer Res., 10, 2168, 10.1158/1078-0432.CCR-03-0035 Chen, 2004, Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome, Mol. Cancer Ther., 3, 1311 Secord, 2005, Phase I/II trial of intravenous Doxil (R) and whole abdomen hyperthermia in patients with refractory ovarian cancer, Int. J. Hyperthermia, 21, 333, 10.1080/02656730500110155 Yarmolenko, 2010, Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours, Int. J. Hyperthermia, 26, 485, 10.3109/02656731003789284 Poon, 2009, Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer, Expert. Opin. Pharmacother., 10, 333, 10.1517/14656560802677874 Gasselhuber, 2010, Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation, Int. J. Hyperthermia, 26, 499, 10.3109/02656731003623590 Negussie, 2011, Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound, Int. J. Hyperthermia, 27, 140, 10.3109/02656736.2010.528140 Li, 2010, Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia, J. Control. Release, 143, 274, 10.1016/j.jconrel.2010.01.006 van der Zee, 2000, Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial, Lancet, 355, 1119, 10.1016/S0140-6736(00)02059-6 Issels, 2010, Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study, Lancet Oncol., 11, 561, 10.1016/S1470-2045(10)70071-1 Song, 1984, Effect of local hyperthermia on blood flow and microenvironment: a review, Cancer Res., 44, 4721s Krawczyk, 2011, Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly(ADP-ribose) polymerase-1 inhibition, Proc. Natl. Acad. Sci. U. S. A., 108, 9851, 10.1073/pnas.1101053108 Paulides, 2007, The HYPERcollar: a novel applicator for hyperthermia in the head and neck, Int. J. Hyperthermia, 23, 567, 10.1080/02656730701670478 de Smet, 2011, Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study, J. Control. Release, 150, 102, 10.1016/j.jconrel.2010.10.036 Poon, 2011, Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer, Future Oncol., 7, 937, 10.2217/fon.11.73 Wood, 2012, Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies, J. Vasc. Interv. Radiol., 23, 248, 10.1016/j.jvir.2011.10.018 Grull, 2012, Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound, J. Control. Release, 161, 317, 10.1016/j.jconrel.2012.04.041 Manzoor, 2012, Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors, Cancer Res., 72, 5566, 10.1158/0008-5472.CAN-12-1683 Mills, 2004, The materials engineering of temperature-sensitive liposomes, Methods Enzymol., 387, 82, 10.1016/S0076-6879(04)87006-X Hossann, 2007, In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes, Biochim. Biophys. Acta, 1768, 2491, 10.1016/j.bbamem.2007.05.021 Li, 1998, Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient, Biochim. Biophys. Acta, 1415, 23, 10.1016/S0005-2736(98)00175-8 Almgren, 2000, Cryo transmission electron microscopy of liposomes and related structures, Colloids Surf. A, 174, 3, 10.1016/S0927-7757(00)00516-1 Roehm, 1991, An improved colorimetric assay for cell-proliferation and viability utilizing the tetrazolium salt XTT, J. Immunol. Methods, 142, 257, 10.1016/0022-1759(91)90114-U Dreher, 2006, Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers, J. Natl. Cancer Inst., 98, 335, 10.1093/jnci/djj070 Gasselhuber, 2012, Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivo validation, Int. J. Hyperthermia, 28, 337, 10.3109/02656736.2012.677930 Banno, 2010, The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo, J. Pharm. Sci., 99, 2295, 10.1002/jps.21988 Al-Jamal, 2012, Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia, Biomaterials, 33, 4608, 10.1016/j.biomaterials.2012.03.018 Unezaki, 1994, Enhanced delivery and antitumor-activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene-glycol in combination with local hyperthermia, Pharm. Res., 11, 1180, 10.1023/A:1018949218380 Hossann, 2010, Size of thermosensitive liposomes influences content release, J. Control. Release, 147, 436, 10.1016/j.jconrel.2010.08.013 Abu Lila, 2012, Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application, Int. J. Pharm., 438, 176, 10.1016/j.ijpharm.2012.08.030 Dicheva, 2012, Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells, Nano Lett. Hare, 2013, Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer, J. Drug Target., 21, 87, 10.3109/1061186X.2012.729215 Li, 2013, Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia, J. Control. Release, 167, 130, 10.1016/j.jconrel.2013.01.026 Averill, 1999, Sensitization to the cytotoxicity of adriamycin by verapamil and heat in multidrug-resistant Chinese hamster ovary cells, Radiat. Res., 151, 694, 10.2307/3580208 Hermisson, 2000, Hyperthermia enhanced chemosensitivity of human malignant glioma cells, Anticancer. Res., 20, 1819 Raaphorst, 2005, The evaluation of thermal cisplatin sensitization in normal and XP human cells using mild hyperthermia at 40 and 41 degrees C, Anticancer. Res., 25, 2649 Kampinga, 2006, Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field, Int. J. Hyperthermia, 22, 191, 10.1080/02656730500532028 Schiffelers, 2003, Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin, J. Control. Release, 91, 115, 10.1016/S0168-3659(03)00240-2 Negussie, 2010, Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome, J. Control. Release, 143, 265, 10.1016/j.jconrel.2009.12.031 Kong, 2000, Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size, Cancer Res., 60, 4440